ISO 22000 is an international standard for food safety management systems, published by the International Organization for Standardization in Geneva. It combines the principles of HACCP (Hazard Analysis and Critical Control Points) with prerequisite programmes covering facility hygiene, personnel training, equipment maintenance, and traceability. Certification requires an independent audit by an accredited body, with annual surveillance audits to maintain compliance.
For supplement and skincare manufacturers, ISO 22000 certification means every stage of production — from raw material receipt through formulation, filling, packaging, and distribution — is documented, monitored, and subject to corrective action when deviations occur. It is not a one-time achievement; it is a continuous management system that requires organisations to identify potential hazards before they materialise and to demonstrate that critical control points are consistently within safe limits.
Genevia Lifesciences is headquartered in Zug, a canton in central Switzerland that has become one of Europe's most concentrated hubs for life-sciences companies. The regulatory environment, combined with proximity to the Swiss Federal Institute of Technology (ETH Zurich) and the University of Basel's pharmaceutical research facilities, creates an ecosystem where scientific rigour is the baseline expectation rather than a differentiator.
In practical terms, ISO 22000 compliance means that every batch of Daily Balancer can be traced back to the specific lot numbers of its 20 individual ingredients, the identity of the production operator, the temperature and humidity conditions during encapsulation, and the results of finished-product testing. If a quality issue were ever identified, the system enables a targeted recall within hours rather than days — a capability that the FDA considers essential for consumer protection.
Beyond certification, Genevia applies additional voluntary standards: GMP (Good Manufacturing Practice) protocols adapted from pharmaceutical production, IFOS third-party testing for every omega-3 batch, and a non-GMO verification process for all botanical ingredients. These overlapping quality systems create redundancy by design — if one checkpoint misses a deviation, the next one catches it.
The Swiss approach to manufacturing is often described as over-engineered. In consumer health products — where the margin between a safe product and a contaminated one can be measured in parts per million — that precision is not excessive. It is essential.